1.Liang YY, Bacanu S, Sreekumar L, Ramos AD, Dai L, Michaelis M, Cinatl J, Seiki T, Cao Y, Coffill CR, Lane DP, Prabhu N, Nordlund P (2021). CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug toxicity. Cell Chem Biol, 2021 S2451-9456(21)00306-8.
2. Sun J, Prabhu N, Tang J, Yang F, Jia L , Xiao K, Tam WL, Nordlund P, Dai L (2021). Recent advances in proteome-wide free target deconvolution for bioactive small molecules. Med Res Rev, 21788 (Online ahead of print)
3. Prabhu N, Dai L, and Nordlund P (2020). CETSA in integrated proteomics studies of cellular processes Curr Opi Chem Biol, Feb;54:54-62
4. Dziekan JM, Wirjanata G, Dai L, Go KD, Yu H, Lim YT, Chen L, Wang LC, Puspita B, Prabhu N, Sobota RM, Nordlund P, Bozdech Z (2020). Cellular thermal shift assay for the identification of drug-target interactions in the Plasmodium falciparum proteome Nature Protocols, 15(6):1881-1921
5. Langebäck A, Bacanu S, Laursen H, Mout L, Seki T, Erkens-Schulze S, Ramos AD, Berggren A, Cao Y, Hartman J, van Weerden W, Bergh J, Nordlund P, Lööf S (2019). CETSA based target engagement of taxanes as biomarkers for efficacy and resistance. Sci Rep 2019 12;9(1):19384